• भारत सरकार के विज्ञान एवम प्रौदयोगिकी मंत्रालय के जैव प्रौदयोगिकी विभाग की स्वायत्त संस्थान
  • AN AUTONOMOUS INSTITUTE OF DEPT. OF BIOTECHNOLOGY, MINISTRY OF SCIENCE AND TECHNOLOGY, GOVT OF INDIA
  • होम
  • संकाय प्रोफ़ाइल
Publication

Selected recent publications

1. Karthikeyan G, Ntsekhe M, Islam S, et al. Mortality and morbidity in adults with rheumatic heart disease. JAMA 2024; doi:10.1001/jama.2024.825

2. Karthikeyan G, Kothari SS. How should the burden of rheumatic heart disease be reduced? Lancet Glob Health. 2023;11:e316-e317.

3. Karthikeyan G, et al. Research priorities for the secondary prevention and management of acute rheumatic fever and rheumatic heart disease: a National Heart, Lung, and Blood Institute workshop report. BMJ Glob Health 2023; 8(Suppl 9):e012468

4. Connolly SJ, Karthikeyan G, Ntsekhe M, et al. Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. N Engl J Med 2022;387:978-988.

5. Karthikeyan G, Mantoo MR, Bhargava B. Choosing the right model for STEMI care in India - Focus should remain on providing timely fibrinolytic therapy, for now. Indian J Med Res 2022 Jul 21. doi: 10.4103/ijmr.ijmr_600_22. 

6. Karthikeyan G, Fung E, Foo R S-Y. Alternative hypothesis to explain disease progression in rheumatic heart disease. Circulation 2020; 142:2091-2094.

7. Karthikeyan G, Connolly SJ, Yusuf S. Overestimation of stroke risk in rheumatic mitral stenosis and the implications for anticoagulation. Circulation 2020; 142: 1697-1699.

8. Karthikeyan G. Tracking the impact of interventions against COVID-19 in the absence of extensive testing. Indian J Med Res 2020;151(2 & 3):114-5.

9. Karthikeyan G, Devasenapathy N, Zuhlke L, Engel ME, Rangarajan S, Teo KK, et al. Digoxin and clinical outcomes in the Global Rheumatic Heart Disease Registry. Heart 2019;105:363-9.

10. Karthikeyan G, Guilherme L. Acute rheumatic fever. Lancet. 2018;392:161-74.

  • GKARTHIKEYAN[AT]THSTI[DOT]RES[DOT]IN